Cognition Therapeutics, Inc. (CGTX)
NCM – Real Time Price. Currency in USD
1.05
+0.04 (3.43%)
Market open: Aug 12, 2026, 12:33 PM EDT
1.01
-0.01 (-0.93%)
Previous after-hours: Aug 11, 2026, 7:39 PM EDT
Find any stock by ticker or company name

NCM – Real Time Price. Currency in USD
1.05
+0.04 (3.43%)
Market open: Aug 12, 2026, 12:33 PM EDT
1.01
-0.01 (-0.93%)
Previous after-hours: Aug 11, 2026, 7:39 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
Cash reserves $34.8M barely cover the upcoming debt maturities $0.0
Total current assets $0.0 are just enough to cover Total current liabilities $0.0, indicating tight liquidity
Debt-to-equity ratio (0.0) is near the industry average, reflecting balanced leverage
Interest coverage ratio (-2,579.3x) is dangerously low, suggesting debt repayment risks
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | N/A | 6.05 | 1.0 | |
| Quick ratio | N/A | 5.63 | 1.0 | |
| Debt to Equity | N/A | 0.30 | 1.0 | |
| Debt to Assets | N/A | 1.04 | 1.0 | |
| Interest coverage | -2579.33 | -16.91 | 1.0 | |
| Weighted average score | 1.0 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | -235K | -252K | -266K | -228K | -190K |
| Operating Income | -44M | -51M | -54M | -48M | -37M |
| Net Income | -21M | -26M | -34M | -23M | -17M |
| EBITDA | -43M | -50M | -54M | -48M | -29M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | -16.67 | 1.0 |
| Next quarter | N/A | -292 | 1.0 |
| Current year | N/A | -5.21 | 1.0 |
| Next year | N/A | 30.2 | 5.5 |
| Weighted average score | 2.1 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | 13.96 | 20 | -61.24 | 7.0 |
| Y/Y | 999 | 41.61 | 63.64 | 43.89 | 10 |
| 3y average | 999 | -7.11 | 22.76 | -16.3 | 5.5 |
| 5y average | 999 | -30.68 | 34.8 | -93.28 | 5.5 |
| Weighted average score | 7.0 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |